Abstract
Intraoperative fluorescent imaging can provide real-time identification of tumours, lymph nodes, nerves and other healthy and malignant tissues during oncological surgery, contributing to better surgical outcomes. Various fluorescent probes have been clinically approved for surgical applications, improving tumour resection precision and preventing iatrogenic injury. In this Review, we discuss the development and application of fluorescent probes for image-guided surgery, including systemically and locally applied probes that are either non-targeted or targeted to specific tumours and tissues. We discuss the optimization and clinical potential of these probes, and highlight their current and future applications in oncological surgery. In addition, we examine the hardware of fluorescence imaging equipment, and discuss how artificial intelligence can enable real-time quantification to guide surgical decision-making. Finally, we highlight the remaining challenges in the field of image-guided surgery, including the need for standardization to achieve regulatory approval of new probes, and the required team effort for new probe development.
Key points
-
Fluorescence image-guided surgery offers real-time intraoperative visualization of tumours and/or nearby healthy tissues, enabling high-precision tumour resection and prevention of iatrogenic injury.
-
Several fluorescence imaging probes have been clinically approved for oncological surgery, including non-targeted and tumour-targeted probes, and various new probes are being explored at the preclinical stage.
-
Hardware improvements and artificial intelligence software of intraoperative fluorescence imaging systems have improved imaging quality and enable image quantification, optimized ergonomics and straightforward human–machine interaction.
-
The clinical translation of new fluorescent imaging probes will require equipment standardization, interdisciplinary cooperation and technological development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mieog, J. S. D. et al. Fundamentals and developments in fluorescence-guided cancer surgery. Nat. Rev. Clin. Oncol. 19, 9–22 (2022).
Hernot, S., van Manen, L., Debie, P., Mieog, J. S. D. & Vahrmeijer, A. L. Latest developments in molecular tracers for fluorescence image-guided cancer surgery. Lancet Oncol. 20, e354–e367 (2019).
Wang, X. et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann. Surg. 274, 97–106 (2021).
Alander, J. T. et al. A review of indocyanine green fluorescent imaging in surgery. Int. J. Biomed. Imaging 2012, 940585 (2012).
Huang, W. et al. Intraoperative fluorescence visualization in thoracoscopic surgery. Ann. Thorac. Surg. https://doi.org/10.1016/j.athoracsur.2022.03.040 (2022).
Hu, Z. et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat. Biomed. Eng. 4, 259–271 (2020). This article reports the first-in-human study of visible, NIR-I and NIR-II multispectral imaging to guide cancer surgery.
Cwalinski, T. et al. Methylene blue — current knowledge, fluorescent properties, and its future use. J. Clin. Med. 9, 3538 (2020).
Zhang, C. et al. Improved generative adversarial networks using the total gradient loss for the resolution enhancement of fluorescence images. Biomed. Opt. Express 10, 4742–4756 (2019). This article demonstrates the potential of AI for intraoperative fluorescence imaging resolution enhancement.
Stammes, M. A. et al. Modalities for image- and molecular-guided cancer surgery. Br. J. Surg. 105, e69–e83 (2018).
Wang, H. et al. Indocyanine green-incorporating nanoparticles for cancer theranostics. Theranostics 8, 1227–1242 (2018).
Crawford, T. et al. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery. Sci. Rep. 10, 18356 (2020).
Nishis, N. et al. Optimal dosing strategy for fluorescence-guided surgery with panitumumab-IRDye800CW in head and neck cancer. Mol. Imaging Biol. 22, 156–164 (2020).
Moore, G. E. Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 106, 130–131 (1947).
Porcu, E. P. et al. Indocyanine green delivery systems for tumour detection and treatments. Biotechnol. Adv. 34, 768–789 (2016).
Chen, Q. Y. et al. Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer: a randomized clinical trial. JAMA Surg. 155, 300–311 (2020).
Dip, F. et al. Randomized trial of near-infrared incisionless fluorescent cholangiography. Ann. Surg. 270, 992–999 (2019).
De Nardi, P. et al. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg. Endosc. 34, 53–60 (2020).
Jørgensen, M. G., Hermann, A. P., Madsen, A. R., Christensen, S. & Sørensen, J. A. Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema. Sci. Rep. 11, 21103 (2021).
Zhang, R. R. et al. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat. Rev. Clin. Oncol. 14, 347–364 (2017).
Ginimuge, P. R. & Jyothi, S. D. Methylene blue: revisited. J. Anaesthesiol. Clin. Pharmacol. 26, 517–520 (2010).
Verbeek, F. P. et al. Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience. J. Urol. 190, 574–579 (2013).
Hillary, S. L., Guillermet, S., Brown, N. J. & Balasubramanian, S. P. Use of methylene blue and near-infrared fluorescence in thyroid and parathyroid surgery. Langenbecks Arch. Surg. 403, 111–118 (2018).
Handgraaf, H. J. M. et al. Intraoperative near-infrared fluorescence imaging of multiple pancreatic neuroendocrine tumors: a case report. Pancreas 47, 130–133 (2018).
Boughey, J. C. et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. Jama 310, 1455–1461 (2013).
Liu, J. et al. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer. Sci. Rep. 9, 13545 (2019).
Cwalinski, T. et al. Methylene blue-current knowledge, fluorescent properties, and its future use. J. Clin. Med. 9, 3538 (2020).
Héritier Barras, A. C., Walder, B. & Seeck, M. Serotonin syndrome following methylene blue infusion: a rare complication of antidepressant therapy. J. Neurol. Neurosurg. Psychiatry 81, 1412–1413 (2010).
Wang, L. M., Banu, M. A., Canoll, P. & Bruce, J. N. Rationale and clinical implications of fluorescein-guided supramarginal resection in newly diagnosed high-grade glioma. Front. Oncol. 11, 666734 (2021).
Sun, Z. et al. Fluorescein-guided surgery for spinal gliomas: analysis of 220 consecutive cases. Int. Rev. Neurobiol. 151, 139–154 (2020).
Acerbi, F. et al. Fluorescein-guided surgery for malignant gliomas: a review. Neurosurg. Rev. 37, 547–557 (2014).
Hadjipanayis, C. G. & Stummer, W. 5-ALA and FDA approval for glioma surgery. J. Neurooncol. 141, 479–486 (2019).
Mahmoudi, K. et al. 5-Aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J. Neurooncol. 141, 595–607 (2019).
Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet. Oncol. 7, 392–401 (2006).
Folli, S. et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proc. Natl Acad. Sci. USA 89, 7973–7977 (1992).
Harlaar, N. J. et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol. Hepatol. 1, 283–290 (2016).
Rosenthal, E. L. et al. Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer. Clin. Cancer Res. 23, 4744–4752 (2017).
Lu, G. et al. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study. Lancet Gastroenterol. Hepatol. 5, 753–764 (2020).
Boogerd, L. S. F. et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol. Hepatol. 3, 181–191 (2018).
Lauwerends, L. J. et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet. Oncol. 22, e186–e195 (2021).
Miller, S. E. et al. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. J. Neurooncol. 139, 135–143 (2018).
Rosenthal, E. L. et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin. Cancer Res. 21, 3658–3666 (2015).
Gao, R. W. et al. Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence. Cancer Res. 78, 5144–5154 (2018).
Warram, J. M. et al. Antibody-based imaging strategies for cancer. Cancer Metastasis Rev. 33, 809–822 (2014).
Goetz, M. et al. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology 138, 435–446 (2010).
de Valk, K. S. et al. First-in-human assessment of cRGD-ZW800-1, a zwitterionic, integrin-targeted, near-infrared fluorescent peptide in colon carcinoma. Clin. Cancer Res. 26, 3990–3998 (2020).
Fidel, J. et al. Preclinical validation of the utility of BLZ-100 in providing fluorescence contrast for imaging spontaneous solid tumors. Cancer Res. 75, 4283–4291 (2015).
Yamada, M. et al. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp. Clin. Trials Commun. 23, 100830 (2021).
Barth, C. W. & Gibbs, S. L. Fluorescence image-guided surgery — a perspective on contrast agent development. Proc. SPIE Int. Soc. Opt. Eng. 11222, 112220J (2020).
van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat. Med. 17, 1315–1319 (2011). This article reports the first-in-human use of intraoperative tumour-specific fluorescence imaging for real-time surgical visualization of cancer.
Hoogstins, C. E. et al. A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer. Clin. Cancer Res. 22, 2929–2938 (2016).
Voskuil, F. J. et al. Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery. Nat. Commun. 11, 3257 (2020).
Zanoni, D. K. et al. Use of ultrasmall core-shell fluorescent silica nanoparticles for image-guided sentinel lymph node biopsy in head and neck melanoma: a nonrandomized clinical trial. JAMA Netw. Open 4, e211936 (2021).
Hu, Z., Chen, W. H., Tian, J. & Cheng, Z. NIRF nanoprobes for cancer molecular imaging: approaching clinic. Trends Mol. Med. 26, 469–482 (2020).
Zeng, W. et al. Ratiometric Imaging of MMP-2 activity facilitates tumor detection using activatable near-infrared fluorescent semiconducting polymer nanoparticles. Small 17, e2101924 (2021).
Blau, R. et al. Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins. Theranostics 8, 3437–3460 (2018).
Kamiya, M. et al. An enzymatically activated fluorescence probe for targeted tumor imaging. J. Am. Chem. Soc. 129, 3918–3929 (2007).
Zhou, F. et al. γ-Glutamyl transpeptidase-activatable near-infrared nanoassembly for tumor fluorescence imaging-guided photothermal therapy. Theranostics 11, 7045–7056 (2021).
Kang, D., Cheung, S. T., Wong-Rolle, A. & Kim, J. Enamine N-oxides: synthesis and application to hypoxia-responsive prodrugs and imaging agents. ACS Cent. Sci. 7, 631–640 (2021).
Chen, X. et al. Synergistic lysosomal activatable polymeric nanoprobe encapsulating pH sensitive imidazole derivative for tumor diagnosis. Small 14, 1703164 (2018).
Steinkamp, P. J. et al. A standardized framework for fluorescence-guided margin assessment for head and neck cancer using a tumor acidosis sensitive optical imaging agent. Mol. Imaging Biol. 23, 809–817 (2021).
Guo, R. et al. GSH activated biotin-tagged near-infrared probe for efficient cancer imaging. Theranostics 9, 3515–3525 (2019).
Unkart, J. T. et al. Intraoperative tumor detection using a ratiometric activatable fluorescent peptide: a first-in-human phase 1 study. Ann. Surg. Oncol. 24, 3167–3173 (2017).
Whitley, M. J. et al. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Sci. Transl. Med. 8, 320ra324 (2016).
Yim, J. J., Tholen, M., Klaassen, A., Sorger, J. & Bogyo, M. Optimization of a protease activated probe for optical surgical navigation. Mol. Pharm. 15, 750–758 (2018).
Zhu, S., Tian, R., Antaris, A. L., Chen, X. & Dai, H. Near-infrared-II molecular dyes for cancer imaging and surgery. Adv. Mater. 31, e1900321 (2019).
O’Connor, J. P. et al. Imaging biomarker roadmap for cancer studies. Nat. Rev. Clin. Oncol. 14, 169–186 (2017).
van Leeuwen, F. W. B. et al. Trending: radioactive and fluorescent bimodal/hybrid tracers as multiplexing solutions for surgical guidance. J. Nucl. Med. 61, 13–19 (2020).
Manca, G. et al. Novel experience in hybrid tracers: clinical evaluation of feasibility and efficacy in using ICG-99mTc nanotop for sentinel node procedure in breast cancer patients. Clin. Nucl. Med. 46, e181–e187 (2021).
Verbeek, F. P. et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int. J. Gynecol. Cancer. 25, 1086–1093 (2015).
Christensen, A. et al. Feasibility of real-time near-infrared fluorescence tracer imaging in sentinel node biopsy for oral cavity cancer patients. Ann. Surg. Oncol. 23, 565–572 (2016).
Hekman, M. C. et al. Tumor-targeted dual-modality imaging to improve intraoperative visualization of clear cell renal cell carcinoma: a first in man study. Theranostics 8, 2161–2170 (2018). This article reports monoclonal antibodies co-labelled with radionuclides and NIR dyes for clinical intraoperative cancer imaging with a high contrast ratio, enabling precise delineation of tumour margins.
Li, D. et al. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using (68)Ga-IRDye800CW-BBN. Theranostics 8, 2508–2520 (2018).
Derks, Y. H. W. et al. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery. Theranostics 9, 6824–6839 (2019).
Demétrio de Souza França, P. et al. A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer. Eur. J. Nucl. Med. Mol. Imaging 48, 3618–3630 (2021).
Kossatz, S. et al. Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers. Nat. Biomed. Eng. 4, 272–285 (2020). This article demonstrates topically applied targeted probes for clinical cancer surgery.
de Souza França, P. D. et al. PARP1: a potential molecular marker to identify cancer during colposcopy procedures. J. Nucl. Med. 62, 941–948 (2021).
Chen, J. et al. Multiplexed endoscopic imaging of Barrett’s neoplasia using targeted fluorescent heptapeptides in a phase 1 proof-of-concept study. Gut 70, 1010–1013 (2021). This article reports multiple molecular targets for imaging in patients.
Pan, Y. et al. Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Sci. Transl. Med. 6, 260ra148 (2014).
Buckle, T. et al. Translation of c-Met targeted image-guided surgery solutions in oral cavity cancer — initial proof of concept data. Cancers 13, 2674 (2021).
Onoyama, H. et al. Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV. Sci. Rep. 6, 26399 (2016).
Mizushima, T. et al. Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV. Head Neck 40, 1466–1475 (2018).
Walker, E. et al. Rapid visualization of nonmelanoma skin cancer. J. Am. Acad. Dermatol. 76, 209–216.e9 (2017).
Walker, E. et al. A protease-activated fluorescent probe allows rapid visualization of keratinocyte carcinoma during excision. Cancer Res. 80, 2045–2055 (2020).
Sensarn, S. et al. A clinical wide-field fluorescence endoscopic device for molecular imaging demonstrating cathepsin protease activity in colon cancer. Mol. Imaging Biol. 18, 820–829 (2016).
Mitsunaga, M. et al. Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe. Gut 62, 1179–1186 (2013).
Yang, R. Q. et al. Surgical navigation for malignancies guided by near-infrared-ii fluorescence imaging. Small Meth. 5, e2001066 (2021).
Carr, J. A. et al. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc. Natl Acad. Sci. USA 115, 4465–4470 (2018).
Cosco, E. D. et al. Flavylium polymethine fluorophores for near- and shortwave infrared imaging. Angew. Chem. 56, 13126–13129 (2017).
Bandi, V. G. et al. Targeted multicolor in vivo imaging over 1,000 nm enabled by nonamethine cyanines. Nat. Meth. 19, 353–358 (2022).
Widen, J. C. et al. AND-gate contrast agents for enhanced fluorescence-guided surgery. Nat. Biomed. Eng. 5, 264–277 (2021). This article reports an ‘AND-Gate’ protease probe that relies on multivariate activation, enabling intraoperative cancer detection, precise treatment and real-time monitoring.
Zheng, X. et al. Successively activatable ultrasensitive probe for imaging tumour acidity and hypoxia. Nat. Biomed. Eng. 1, 0057 (2017).
Cornelissen, B. et al. Translational molecular imaging in exocrine pancreatic cancer. Eur. J. Nucl. Med. Mol. Imaging 45, 2442–2455 (2018).
Hadjipanayis, C. G., Widhalm, G. & Stummer, W. What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery 77, 663–673 (2015).
Pogue, B. W. et al. Fluorescence-guided surgery and intervention — an AAPM emerging technology blue paper. Med. Phys. 45, 2681–2688 (2018).
Billings, C., Langley, M., Warrington, G., Mashali, F. & Johnson, J. A. Magnetic particle imaging: current and future applications, magnetic nanoparticle synthesis methods and safety measures. Int. J. Mol. Sci. 22, 7651 (2021).
Song, G. et al. Janus iron oxides @ semiconducting polymer nanoparticle tracer for cell tracking by magnetic particle imaging. Nano Lett. 18, 182–189 (2018).
Wang, G. et al. Sensitive and specific detection of breast cancer lymph node metastasis through dual-modality magnetic particle imaging and fluorescence molecular imaging: a preclinical evaluation. Eur. J. Nucl. Med. Mol. Imaging 49, 2723–2734 (2022). This article describes the combination of fluorescence molecular imaging and MPI for the precise and quantitative identification of metastatic lymph nodes without penetration depth limitation.
Choi, H. S. et al. Design considerations for tumour-targeted nanoparticles. Nat. Nanotechnol. 5, 42–47 (2010).
Yang, J. et al. Gold/α-lactalbumin nanoprobes for the imaging and treatment of breast cancer. Nat. Biomed. Eng. 4, 686–703 (2020).
Shen, D. et al. Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2. Nat. Biomed. Eng. 4, 298–313 (2020).
Ayo, A. & Laakkonen, P. Peptide-based strategies for targeted tumor treatment and imaging. Pharmaceutics 13, 481 (2021).
Zhang, Z. et al. Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China. Eur. J. Nucl. Med. Mol. Imaging 49, 2531–2543 (2022).
Vahrmeijer, A. L., Hutteman, M., van der Vorst, J. R., van de Velde, C. J. & Frangioni, J. V. Image-guided cancer surgery using near-infrared fluorescence. Nat. Rev. Clin. Oncol. 10, 507–518 (2013).
Singhal, S. The future of surgical oncology: image-guided cancer surgery. JAMA Surg. 151, 184–185 (2016).
Hyun, H. et al. Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging. Nat. Med. 21, 192–197 (2015).
Wang, K. et al. Optical molecular imaging frontiers in oncology: the pursuit of accuracy and sensitivity. Engineering 1, 308–323 (2015).
KleinJan, G. H. et al. Toward (hybrid) navigation of a fluorescence camera in an open surgery setting. J. Nucl. Med. 57, 1650–1653 (2016).
van Oosterom, M. N. et al. Extending the hybrid surgical guidance concept with freehand fluorescence tomography. IEEE Trans. Med. Imaging 39, 226–235 (2020).
Kitai, T., Inomoto, T., Miwa, M. & Shikayama, T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12, 211–215 (2005).
van den Berg, N. S. et al. (Near-infrared) Fluorescence-guided surgery under ambient light conditions: a next step to embedment of the technology in clinical routine. Ann. Surg. Oncol. 23, 2586–2595 (2016).
Elliott, J. T. et al. Review of fluorescence guided surgery visualization and overlay techniques. Biomed. Opt. Express 6, 3765–3782 (2015).
Glatz, J. et al. Concurrent video-rate color and near-infrared fluorescence laparoscopy. J. Biomed. Opt. 18, 101302 (2013).
Fengler, J. Near-infrared fluorescence laparoscopy — technical description of PINPOINT® a novel and commercially available system. Colorectal Dis. 17, 3–6 (2015).
Troyan, S. L. et al. The FLARE™ intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann. Surg. Oncol. 16, 2943–2952 (2009).
Ottermo, M. V. et al. The role of tactile feedback in laparoscopic surgery. Surg. Laparosc. Endosc. Percutan. Tech. 16, 390–400 (2006).
Keating, J. et al. Near-infrared intraoperative molecular imaging can locate metastases to the lung. Ann. Thorac. Surg. 103, 390–398 (2017).
Graves, C. E. & Duh, Q.-Y. Fluorescent technologies for intraoperative parathyroid identification. Ann. Thyroid. 5, 26 (2020).
Behrooz, A. et al. Multispectral open-air intraoperative fluorescence imaging. Opt. Lett. 42, 2964–2967 (2017).
He, K. et al. Comparison between the indocyanine green fluorescence and blue dye methods for sentinel lymph node biopsy using novel fluorescence image-guided resection equipment in different types of hospitals. Transl. Res. 178, 74–80 (2016).
Doenst, T., Diab, M., Sponholz, C., Bauer, M. & Färber, G. The opportunities and limitations of minimally invasive cardiac surgery. Dtsch. Arztebl Int. 114, 777–784 (2017).
DSouza, A., Lin, H., Henderson, E., Samkoe, K. & Pogue, B. Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J. Biomed. Opt. 21, 080901 (2016).
Mao, Y. et al. Development and application of the near-infrared and white-light thoracoscope system for minimally invasive lung cancer surgery. J. Biomed. Opt. 22, 066002 (2017).
Daskalaki, D., Aguilera, F., Patton, K. & Giulianotti, P. C. Fluorescence in robotic surgery. J. Surg. Oncol. 112, 250–256 (2015).
Tjalma, J. J. J. et al. Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut 69, 406–410 (2020).
Achterberg, F. B. et al. Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery. Eur. J. Nucl. Med. Mol. Imaging 48, 332–339 (2021).
Koga, H. et al. Comparison of 2K and 4K imaging systems for laparoscopic repair of choledochal cyst in children. J. Pediatr. Surg. 57, 235–238 (2022).
Liu, Y. et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. Transl. Res. 162, 324–331 (2013).
Shao, P. et al. Designing a wearable navigation system for image-guided cancer resection surgery. Ann. Biomed. Eng. 42, 2228–2237 (2014).
Tonetti, J., Boudissa, M., Kerschbaumer, G. & Seurat, O. Role of 3D intraoperative imaging in orthopedic and trauma surgery. Orthop. Traumatol. Surg. Res. 106, S19–S25 (2020).
Quang, T. T., Chen, W. F., Papay, F. A. & Liu, Y. Dynamic, real-time, fiducial-free surgical navigation with integrated multimodal optical imaging. IEEE Photonics J. 13, 1–13 (2021).
Azargoshasb, S. et al. Advancing intraoperative magnetic tracing using 3D freehand magnetic particle imaging. Int. J. Comput. Assist. Radiol. Surg. 17, 211–218 (2022).
Mason, E. E. et al. Concept for using magnetic particle imaging for intraoperative margin analysis in breast-conserving surgery. Sci. Rep. 11, 13456 (2021).
de Jongh, S. J. et al. Back-table fluorescence-guided imaging for circumferential resection margin evaluation using bevacizumab-800CW in patients with locally advanced rectal cancer. J. Nucl. Med. 61, 655–661 (2020).
Zhang, P. et al. Real-time navigation for laparoscopic hepatectomy using image fusion of preoperative 3D surgical plan and intraoperative indocyanine green fluorescence imaging. Surg. Endosc. 34, 3449–3459 (2020).
Zhang, C., Wang, K. & Tian, J. Adaptive brightness fusion method for intraoperative near-infrared fluorescence and visible images. Biomed. Opt. Express 13, 1243–1260 (2022).
Quang, T., Zhou, M., Papay, F. & Liu, Y. in 2018 IEEE Int. Symp. Signal Processing and Information Technology (ISSPIT) 1–6 (2018).
Ma, Z., Wang, F., Wang, W., Zhong, Y. & Dai, H. Deep learning for in vivo near-infrared imaging. Proc. Natl Acad. Sci. USA 118, e2021446118 (2021).
Koch, M. et al. Video-rate optical flow corrected intraoperative functional fluorescence imaging. J. Biomed. Opt. 19, 046012 (2014).
Feruglio, P. F. et al. Noise suppressed, multifocus image fusion for enhanced intraoperative navigation. J. Biophotonics 6, 363–370 (2013).
Madani, A. et al. Artificial intelligence for intraoperative guidance: using semantic segmentation to identify surgical anatomy during laparoscopic cholecystectomy. Ann. Surg. 276, 363–369 (2022).
Shademan, A. et al. Supervised autonomous robotic soft tissue surgery. Sci. Transl. Med. 8, 337ra364 (2016).
Cahill, R. A. et al. Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification. Br. J. Surg. 108, 5–9 (2020).
Shen, B. et al. Real-time intraoperative glioma diagnosis using fluorescence imaging and deep convolutional neural networks. Eur. J. Nucl. Med. Mol. Imaging 48, 3482–3492 (2021).
Ishizawa, T. et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 115, 2491–2504 (2009).
He, K. S. et al. Efficacy of near-infrared fluorescence-guided hepatectomy for the detection of colorectal liver metastases: a randomized controlled trial. J. Am. Coll. Surg. 234, 130–137 (2022).
Garrido, A. & Djouder, N. Cirrhosis: a questioned risk factor for hepatocellular carcinoma. Trends Cancer 7, 29–36 (2021).
Kanwal, F. & Singal, A. G. Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology 157, 54–64 (2019).
Marino, M. V., Podda, M., Fernandez, C. C., Ruiz, M. G. & Fleitas, M. G. The application of indocyanine green-fluorescence imaging during robotic-assisted liver resection for malignant tumors: a single-arm feasibility cohort study. HPB 22, 422–431 (2020).
Yu, W. Q., Liu, R., Zhou, Y. & Gao, H. L. Size-tunable strategies for a tumor targeted drug delivery system. ACS Cent. Sci. 6, 100–116 (2020).
Tang, C., Du, Y., Liang, Q., Cheng, Z. & Tian, J. Development of a novel histone deacetylase-targeted near-infrared probe for hepatocellular carcinoma imaging and fluorescence image-guided surgery. Mol. Imaging Biol. 22, 476–485 (2020).
Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557–588 (2020).
Zhang, H., Yang, T., Wu, M. C. & Shen, F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 379, 198–205 (2016).
Zhang, Y. et al. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: a pilot study (with video). Surgery 171, 1589–1595 (2022).
Tummers, W. S. et al. Intraoperative pancreatic cancer detection using tumor-specific multimodality molecular imaging. Ann. Surg. Oncol. 25, 1880–1888 (2018).
Tummers, W. S. et al. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. HPB 21, 883–890 (2019).
Hoogstins, C. E. S. et al. Image-guided surgery in patients with pancreatic cancer: first results of a clinical trial using SGM-101, a novel carcinoembryonic antigen-targeting, near-infrared fluorescent agent. Ann. Surg. Oncol. 25, 3350–3357 (2018).
Zhou, J., Yang, F., Jiang, G. C. & Wang, J. Applications of indocyanine green based near-infrared fluorescence imaging in thoracic surgery. J. Thorac. Dis. 8, S738–S743 (2016).
Newton, A. D., Predina, J. D., Nie, S. M., Low, P. S. & Singhal, S. Intraoperative fluorescence imaging in thoracic surgery. J. Surg. Oncol. 118, 344–355 (2018).
Matsuura, Y., Ichinose, J., Nakao, M., Okumura, S. & Mun, M. Recent fluorescence imaging technology applications of indocyanine green in general thoracic surgery. Surg. Today 50, 1332–1342 (2020).
Kim, H. K. et al. Intraoperative pulmonary neoplasm identification using near-infrared fluorescence imaging. Eur. J. Cardiothorac. Surg. 49, 1497–1502 (2016).
Okusanya, O. T. et al. Intraoperative near-infrared imaging can identify pulmonary nodules. Ann. Thorac. Surg. 98, 1223–1230 (2014).
Mao, Y. M. et al. The identification of sub-centimetre nodules by near-infrared fluorescence thoracoscopic systems in pulmonary resection surgeries. Eur. J. Cardiothorac. Surg. 52, 1190–1196 (2017).
Li, H. et al. Clinical application of near-infrared thoracoscope with indocyanine green in video-assisted thoracoscopic bullectomy. J. Thorac. Dis. 8, 1841–1845 (2016).
Li, H., Zhou, J., Yang, F. & Wang, J. Identifying interlobar fissure in a Craig grade 4 fissureless patient by near-infrared thoracoscopy. J. Thorac. Dis. 10, E52–E54 (2018).
Quan, Y. H. et al. Evaluation of intraoperative near-infrared fluorescence visualization of the lung tumor margin with indocyanine green inhalation. JAMA Surg. 155, 732–740 (2020).
Predina, J. D., Newton, A., Connolly, C. & Singhal, S. Folate receptor-targeted molecular imaging improves identification of malignancy during pulmonary resection: a case report. J. Cardiothorac. Surg. 12, 110 (2017).
Predina, J. D. et al. Intraoperative molecular imaging combined with positron emission tomography improves surgical management of peripheral malignant pulmonary nodules. Ann. Surg. 266, 479–488 (2017).
Gangadharan, S. et al. Multiinstitutional phase 2 clinical trial of intraoperative molecular imaging of lung cancer. Ann. Thorac. Surg. 112, 1150–1159 (2021).
Wang, X. J. et al. Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery. Surg. Endosc. 36, 3994–4003 (2022).
Huang, Z.-N. et al. Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based on propensity matching. Gastric Cancer 24, 1355–1364 (2021).
Zhong, Q. et al. Clinical implications of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for patients with gastric cancer: a cohort study from two randomized, controlled trials using individual patient data. Int. J. Surg. 94, 106120 (2021).
Burggraaf, J. et al. Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. Nat. Med. 21, 955–961 (2015).
Schaap, D. P. et al. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Br. J. Surg. 107, 334–337 (2020).
Nishigori, N. et al. Visualization of lymph/blood flow in laparoscopic colorectal cancer surgery by ICG fluorescence imaging (Lap-IGFI). Ann. Surg. Oncol. 23, 266–274 (2016).
Satoyoshi, T. et al. Timing of indocyanine green injection prior to laparoscopic colorectal surgery for tumor localization: a prospective case series. Surg. Endosc. 35, 763–769 (2021).
Blair, S. et al. Hexachromatic bioinspired camera for image-guided cancer surgery. Sci. Transl. Med. 13, eaaw7067 (2021).
Zhang, C. et al. Methylene blue-based near-infrared fluorescence imaging for breast cancer visualization in resected human tissues. Technol. Cancer Res. Treat. 18, 1533033819894331 (2019).
Lamberts, L. E. et al. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin. Cancer Res. 23, 2730–2741 (2017).
Frumovitz, M. et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 19, 1394–1403 (2018).
Randall, L. M., Wenham, R. M., Low, P. S., Dowdy, S. C. & Tanyi, J. L. A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-α positive ovarian cancer. Gynecol. Oncol. 155, 63–68 (2019).
Chan, D. T. M., Sonia, H. Y. P. & Poon, W. S. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience. Asian J. Surg. 41, 467–472 (2018).
Shi, X. et al. Near-infrared window II fluorescence image-guided surgery of high-grade gliomas prolongs the progression-free survival of patients. IEEE Trans. Biomed. Eng. 69, 1889–1900 (2022).
Nishio, N. et al. Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer. Nat. Commun. 10, 5044 (2019).
van Keulen, S. et al. The sentinel margin: intraoperative ex vivo specimen mapping using relative fluorescence intensity. Clin. Cancer Res. 25, 4656–4662 (2019).
Cao, C. et al. Intraoperative near-infrared II window fluorescence imaging-assisted nephron-sparing surgery for complete resection of cystic renal masses. Clin. Transl. Med. 11, e604 (2021).
Shang, W. et al. A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer. Eur. J. Nucl. Med. Mol. Imaging https://doi.org/10.1007/s00259-022-05701-3 (2022).
Walsh, E. M. et al. Fluorescence imaging of nerves during surgery. Ann. Surg. 270, 69–76 (2019). This article summarizes the value of imaging nerves during cancer operation.
Wang, L. G. et al. Near-infrared nerve-binding fluorophores for buried nerve tissue imaging. Sci. Transl. Med. 12, eaay0712 (2020).
He, K. S. et al. Near-infrared intraoperative imaging of thoracic sympathetic nerves: from preclinical study to clinical trial. Theranostics 8, 304–313 (2018).
He, K. et al. Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy. Eur. J. Nucl. Med. Mol. Imaging https://doi.org/10.1007/s00259-022-05686-z (2022).
Pei, G. et al. The safety and feasibility of intraoperative near-infrared fluorescence imaging with indocyanine green in thoracoscopic sympathectomy for primary palmar hyperhidrosis. Thorac. Cancer 11, 943–949 (2020).
Wang, P. A. et al. Detection of the common bile duct in difficult bile duct exploration using indocyanine green fluorescence imaging: a case report. Photodiagnosis Photodyn. Ther. 36, 102610 (2021).
Yang, F. et al. Near-infrared fluorescence-guided thoracoscopic surgical intervention for postoperative chylothorax. Interact. Cardiovasc. Thorac. Surg. 26, 171–175 (2018).
Morales-Conde, S. et al. Fluorescence angiography with indocyanine green (ICG) to evaluate anastomosis in colorectal surgery: where does it have more value? Surg. Endosc. 34, 3897–3907 (2020).
Ye, Z. P., Yang, X. Y., Li, W. S., Hou, B. & Guo, Y. Microsurgical resection of cervical spinal cord arteriovenous malformations: report of 6 cases. World Neurosurg. 96, 362–369 (2016).
Maheshwari, A. & Finger, P. T. Cancers of the eye. Cancer Metastasis Rev. 37, 677–690 (2018).
Koch, M., Symvoulidis, P. & Ntziachristos, V. Tackling standardization in fluorescence molecular imaging. Nat. Photonics 12, 505–515 (2018). This article reports high-fidelity fluorescence imaging, and approaches to standardization in intraoperative fluorescence imaging.
Linssen, M. D. et al. Roadmap for the development and clinical translation of optical tracers cetuximab-800CW and trastuzumab-800CW. J. Nucl. Med. 60, 418–423 (2019).
Souto, E. B. et al. Nanopharmaceutics: part I — clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics 12, 146 (2020).
Chapman, S. et al. Nanoparticles for cancer imaging: the good, the bad, and the promise. Nano Today 8, 454–460 (2013).
Pogue, B. W. & Rosenthal, E. L. Review of successful pathways for regulatory approvals in open-field fluorescence-guided surgery. J. Biomed. Opt. 26, 030901 (2021).
Tummers, W. S. et al. Regulatory aspects of optical methods and exogenous targets for cancer detection. Cancer Res. 77, 2197–2206 (2017).
Acknowledgements
The authors thank Z. Wang, X. Zhang and K. M. von Deneen for their advisory help with this article. The authors received support from the Ministry of Science and Technology of China under Grant No. 2017YFA0205200, the National Natural Science Foundation of China under Grant Nos 62027901, 92159305, 81930053, 81227901 and 82272029, the Beijing Science Fund under Grant No. JQ22013 and the Excellent Member Project of Youth Innovation Promotion Association CAS under Grant No. 2016124.
Author information
Authors and Affiliations
Contributions
J.T. contributed to the conception of the Review. All authors contributed to the literature research, and to the writing and editing of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Bioengineering thanks Jan Grimm, Ben Mclarne and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Good manufacturing practices: https://www.iso.org/standard/36437.html
Investigational new drug application recommendations: https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, K., Du, Y., Zhang, Z. et al. Fluorescence image-guided tumour surgery. Nat Rev Bioeng 1, 161–179 (2023). https://doi.org/10.1038/s44222-022-00017-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44222-022-00017-1
This article is cited by
-
Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy
Nature Nanotechnology (2024)
-
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging (2024)
-
Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes
European Journal of Nuclear Medicine and Molecular Imaging (2023)